Human Cathepsin E Antibody, R&D Systems™

Cathepsin E

Monoclonal

LYOPH

Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL

NP_001901

CTSE

Mouse myeloma cell line NS0-derived recombinant human Cathepsin E Gln18-Pro396 Accession # NP_001901

500 μg

Primary

Detects human Cathepsin E in direct ELISAs and Western blots. It recognizes both the pro and mature forms of recombinant human (rh) Cathepsin E. In Western blots, 100% cross-reactivity with recombinant mouse (rm) Cathepsin E and recombinant human (rh) BACE is observed under reducing conditions. Under non-reducing conditions, less than 1% cross-reactivity with rmCathepsin E and rhBACE-1 is observed. Less than 1% cross-reactivity with rhCathepsin D is observed under both reducing and non-reducing conditions.

Human

Purified

Western Blot, Immunoprecipitation

212211

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CATE, cathepsin E, CTSE, EC 3.4.23, EC 3.4.23.34, erythrocyte membrane aspartic proteinase, slow-moving proteinase

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

1510

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2a